Didn't the headline below help ease your butterflies a few weeks ago?
Anavex Life Sciences Promotes Walter E Kaufmann, M.D. to Chief Scientific Officer and Appoints Edward R Hammond, M.D., M.P.H., Ph.D., as Chief Medical Officer
And of course, there's the upgrade from P2b/3 to a pivotal P3.
The two events...plus a rising share price...helped alleviate most of my butterflies.
Sleeping much better now. :-)